Thallium-201-chloride scintigraphy in staging and monitoring radiotherapy response in follicular lymphoma patients

Radiotherapy and Oncology

Volumn 69, Issue 3, 2003, Pages 323-328

  Haas, Rick L M ^a   Valdés Olmos, Renato A ^a   Hoefnagel, Cornelis A ^a   Verheij, Marcel ^a   De Jong, Daphne ^a   Hart, Augustinus A M ^a   Bartelink, Harry ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Lymphoma; Radiotherapy; Response assessment; Staging; Thallium 201 scintigraphy

Indexed keywords

THALLIUM CHLORIDE TL 201;

ABDOMEN; ADULT; AGED; ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; AXILLA; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; LYMPH NODE; MALE; MEDIASTINUM; NECK; PATIENT MONITORING; PERFORMANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIATION RESPONSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN; STANDARD; TREATMENT OUTCOME; TUMOR BIOPSY; WHOLE BODY SCINTISCANNING;

EID: 0344440824     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.08.001     Document Type: Article

References (48)

1. Abdel-Dayem H.M., Bag R., Macapinlac H., et al. Diffuse Tl-201 uptake in the lungs. Etiologic classification and pattern recognition. Clin Nucl Med. 20:1995;164-172.
2. Abdel-Dayem H.M., Bag R., DiFabrizio L., et al. Evaluation of sequential thallium and gallium scans of the chest in AIDS patients. J Nucl Med. 37:1996;1662-1667.
3. Abdel-Dayem H.M., Naddaf S.Y., Omar W.S., Aziz M., Gillooley J. Delayed positive thallium uptake in large B-cell non-Hodgkin's malignant lymphoma. J Nucl Med. 38:1997;1213-1215.
4. Arbab A.S., Koizumi K., Arai T., Toyama K., Araki T. Application of Tc-99m-tetrofosmin as a tumor imaging agent: comparison with Tl-201. Ann Nucl Med. 10:1996;271-274.
5. Arthur J.E., Kehoe K., Van den Abbeele A.D. Thallium-201 scintigraphy in low grade non-Hodgkin's lymphoma. J Nucl Med. 43:1998;258.
6. Buscombe J.R., Cwikla J.B., Thakrar D.S., Hilson A.J. Scintigraphic imaging of breast cancer: a review. Nucl Med Commun. 18:1997;698-709.
7. Cavalieri R.R. Nuclear imaging in the management of thyroid carcinoma. Thyroid. 6:1996;485-492.
8. Cheson B.D., Horning S.J., Coiffier B., et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 17:1999;1244-1253.
9. Coakley A.J. Parathyroid imaging. Nucl Med Commun. 16:1995;522-533.
10. Collett D. Modelling binary data. 1991;Chapman & Hall, London.
11. De Los Santos J.F., Mendenhall N.P., Lynch J.W. Is comprehensive lymphatic irradiation for low grade non-Hodgkin's lymphoma curative treatment? Long-term experience at a single institution. Int J Radiat Oncol Biol Phys. 38:1997;3-8.
12. Fletcher B.D., Kauffman W.M., Kaste S.C., et al. Use of Tl-201 to detect untreated pediatric Hodgkin disease. Radiology. 196:1995;851-855.
13. Fletcher B.D., Xiong X., Kauffman W.M., Kaste S.C., Hudson M.M. Hodgkin's disease: use of Tl-201 to monitor mediastinal involvement. Radiology. 209:1998;471-475.
14. Front D., Israel O. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Semin Nucl Med. 25:1995;60-71.
15. Gregor R.T., Valdes-Olmos R., Koops W., Balm A.J., Hilgers F.J., Hoefnagel C.A. Preliminary experience with thallous chloride Tl201-labeled single-photon emission computed tomography scanning in head and neck cancer. Arch Otolaryngol Head Neck Surg. 122:1996;509-514.
16. Haas R.L.M., Poortmans P., de Jong D., et al. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol. 21:2003;2474-2480.
17. Harris E.W., Rakow J.I., Weiner M., Agress H. Jr. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease. J Nucl Med. 34:1993;1326-1330.
18. Hoefnagel C.A., Delprat C.C., Marcuse H.R., de Vijlder J.J.M. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med. 27:1986;1854-1857.
19. Hoffmann M., Kletter K., Diemling M., et al. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose(F18-FDG) does not visualise extranodal B-cell lymphoma of the mucosa-associatedlymphoid tissue (MALT)-type. Ann Oncol. 10:1999;1185-1189.
20. Horning S.J. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol. 20:1993;75-88.
21. Husson H., Carideo E.G., Neuberg D., et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arays. Blood. 99:2002;282-289.
22. Ishibashi M., Nonoshita M., Uchida M., et al. Bone marrow uptake of thallium-201 before and after therapy in multiple myeloma. J Nucl Med. 39:1998;473-475.
23. Jerusalem G., Beguin Y., Najjar F., et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol. 12:2001;825-830.
24. Kessler L.S., Ruiz A., Donovan Post M.J., Ganz W.I., Brandon A.H., Foss J.N. Thallium-201 brain SPECT of lymphoma in AIDS patients: pitfalls and technique optimization. Am J Neuroradiol. 19:1998;1105-1109.
25. Leskinen-Kallio S., Ruotsalainen U., Nagren K., Teras M., Joensuu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med. 32:1991;1211-1218.
26. Limpens J., Stad R., Vos C., et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 85:1995;2528-2536.
27. Lorberboym M., Wallach F., Estok L., et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. J Nucl Med. 39:1998;1366-1369.
28. MacManus M.P., Hoppe R.T. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? J Clin Oncol. 14:1996;1282-1290.
29. Mandigers C.M., Meijerink J.P., Mensink E.J., et al. Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma. Blood. 98:2001;940-944.
30. Moog F., Bangerter M., Diederichs C.G., et al. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodalstaging. Radiology. 203:1997;795-800.
31. Nadel H.R. Thallium-201 for oncological imaging in children. Semin Nucl Med. 23:1993;243-254.
32. Niemeyer M.G., Kuijper A.F., Meeder J.G., Cramer M.J., Cleophas A.J., van der Wall E.E. Comparison of thallium scintigraphy and positron emission tomography. Angiology. 48:1997;843-853.
33. O'Brien M.E., Easterbrook P., Powell J., et al. The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med. 80:1991;651-660.
34. Prekeges J.L., Eisenberg B. Parathyroid scintigraphy. J Nucl Med Technol. 25:1997;59-65.
35. Roach P.J., Janicek M.J., Kaplan W.D. Bone lymphoma. Comparison of Tl-201 and Ga-67 citrate scintigraphy in assessment of treatment response. Clin Nucl Med. 21:1996;689-694.
36. Roach P.J., Arthur C.K. Comparison of thallium-201 and gallium-67 scintigraphy in soft tissue and bone marrow multiple myeloma: a case report. Australas Radiol. 41:1997;67-69.
37. Roach P.J., Cooper R.A., Arthur C.K., Ravich R.B. Comparison of thallium-201 and gallium-67 scintigraphy in the evaluation of non-Hodgkin's lymphoma. Aust N Z J Med. 28:1998;33-38.
38. Roebuck D.J., Nicholls W.D., Bernard E.J., Kellie S.J., Howman-Giles R. Misleading leads. Thallium-201 uptake in rebound thymic hyperplasia. Med Pediatr Oncol. 30:1998;297-300.
39. Sayman H.B., Sonmezoglu K., Altiok E., Devranoglu G., Ferhanoglu B. Unexpected bone marrow uptake of thallium-201 in nonsecretory myeloma. J Nucl Med. 36:1995;250-251.
40. Sehweil A., McKillop J.H., Ziada G., Al-Sayed M., Abdel-Dayem H., Omar Y.T. The optimum time for tumor imaging with thallium-201. Eur J Nucl Med. 13:1988;527-529.
41. Sehweil A.M., McKillop J.H., Milroy R., Wilson R., Abdel-Dayem H.M., Omar Y.T. Mechanism of 201Tl uptake in tumors. Eur J Nucl Med. 15:1989;376-379.
42. Sehweil A.M., McKillop J.H., Milroy R., et al. 201Tl scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun. 11:1990;263-269.
43. Sisson J.C. Selection of the optimal scanning agent for thyroid cancer. Thyroid. 7:1997;295-302.
44. Sluyser M., Hoefnagel C.A. Breast carcinomas detected by thallium-201 scintigraphy. Cancer Lett. 40:1988;161-168.
45. Stuschke M., Hoederath A., Sack H., et al. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-fruhe Studien. Cancer. 80:1997;2273-2284.
46. Sutcliffe S.B., Gospodarowicz M.K., Bush R.S., et al. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol. 4:1985;211-223.
47. Van Amsterdam J.A., Kluin-Nelemans J.C., van Eck-Smit B.L., Pauwels E.K. Role of 67Ga scintigraphy in localization of lymphoma. Ann Hematol. 72:1996;202-207.
48. Waxman A.D., Eller D., Ashook G., et al. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma. J Nucl Med. 37:1996;46-50.